Literature DB >> 12198808

Neurofilaments in diabetic neuropathy.

Paul Fernyhough1, Robert E Schmidt.   

Abstract

This review discusses the role of abnormal neurofilament (NF) expression, processing, and structure as an etiological factor in diabetic neuropathy. Diabetic sensory and autonomic neuropathy in humans is associated with a spectrum of structural changes in peripheral nerve that includes axonal degeneration, paranodal demyelination, and loss of myelinated fibers-- the latter is probably the result of a dying-back of distal axons. NF filaments are composed of three subunit proteins, NFL, NFM, and NFH, and are major constituents of the axonal cylinder. It is clear that any abnormality in synthesis, delivery, or processing of these critical proteins could lead to severe impairments in axon structure and function. This article describes mechanisms of synthesis, phosphorylation, and delivery of NF and discusses how these processes may be abnormal in diabetics. The pathological alterations in the ganglion and preipheral nerve that occur in sensory and autonomic neuropath will be outlined and related to possible abnormal processing of NF. A major focus is the role or aberrant NF phosphorylation and its possible involvement in the imparied delivery of NF to the distal axon. Identification of stress-activated protein kinases (SAPKs) as NF kinases is discussed in detail and it is proposed that hyperglycemia-induced activation of SAPKs may be a primary etiological event in diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198808     DOI: 10.1016/s0074-7742(02)50075-1

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  9 in total

1.  Mitochondrial stress and the pathogenesis of diabetic neuropathy.

Authors:  Paul Fernyhough; Subir K Roy Chowdhury; Robert E Schmidt
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01-01

Review 2.  Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes.

Authors:  Subir K Roy Chowdhury; Rick T Dobrowsky; Paul Fernyhough
Journal:  Mitochondrion       Date:  2011-07-02       Impact factor: 4.160

3.  Role of oxidative stress in rabies virus infection of adult mouse dorsal root ganglion neurons.

Authors:  Alan C Jackson; Wafa Kammouni; Elena Zherebitskaya; Paul Fernyhough
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

4.  Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetes.

Authors:  Hideki Kamiya; Weixian Zhang; Anders A F Sima
Journal:  Exp Diabetes Res       Date:  2009-10-12

5.  Effects of hyperglycemia on rat cavernous nerve axons: a functional and ultrastructural study.

Authors:  Elena G Zotova; Herbert H Schaumburg; Cedric S Raine; Barbara Cannella; Moses Tar; Arnold Melman; Joseph C Arezzo
Journal:  Exp Neurol       Date:  2008-07-18       Impact factor: 5.330

Review 6.  Impairment of Axonal Transport in Diabetes: Focus on the Putative Mechanisms Underlying Peripheral and Central Neuropathies.

Authors:  Filipa I Baptista; Helena Pinheiro; Catarina A Gomes; António F Ambrósio
Journal:  Mol Neurobiol       Date:  2018-07-12       Impact factor: 5.590

7.  Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling.

Authors:  Noha F Abdelkader; Marawan A Elbaset; Passant E Moustafa; Sherehan M Ibrahim
Journal:  Arch Pharm Res       Date:  2022-06-29       Impact factor: 6.010

8.  Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes.

Authors:  Xiaona Qiao; Shuo Zhang; Weiwei Zhao; Hongying Ye; Yehong Yang; Zhaoyun Zhang; Qing Miao; Renming Hu; Yiming Li; Bin Lu
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

9.  The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance.

Authors:  Yu-Peng Li; Zhong-Qing Yan; Li-Ping Han; Ai-Li Yin; Jin-Yong Xu; Ya-Ran Zhai; Sai Hao; Lin Zhang; Yun Xie
Journal:  Diabetes Ther       Date:  2019-10-30       Impact factor: 2.945

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.